|
LOC100132707 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.831500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.218560E-01 |
| Normal-vs-Stage2 |
6.268800E-01 |
| Normal-vs-Stage3 |
4.228400E-01 |
| Normal-vs-Stage4 |
3.756600E-01 |
| Stage1-vs-Stage2 |
7.939200E-01 |
| Stage1-vs-Stage3 |
1.392170E-01 |
| Stage1-vs-Stage4 |
2.732000E-01 |
| Stage2-vs-Stage3 |
3.423000E-01 |
| Stage2-vs-Stage4 |
3.717000E-01 |
| Stage3-vs-Stage4 |
8.731000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.303600E-02 |
| Normal-vs-AfricanAmerican |
8.938800E-01 |
| Normal-vs-Asian |
3.977600E-02 |
| Caucasian-vs-AfricanAmerican |
5.859800E-02 |
| Caucasian-vs-Asian |
1.972640E-01 |
| AfricanAmerican-vs-Asian |
2.622400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.388230E-01 |
| Normal-vs-Female |
8.586200E-02 |
| Male-vs-Female |
4.269600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.004800E-01 |
| Normal-vs-Extreme_Weight |
5.895600E-01 |
| Normal-vs-Obese |
1.541980E-01 |
| Normal-vs-Extreme_Obese |
9.043400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.269600E-01 |
| Normal_Weight-vs-Obese |
2.429200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.543800E-01 |
| Extreme_Weight-vs-Obese |
5.107200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.218200E-01 |
| Obese-vs-Extreme_Obese |
6.245000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.383000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.675500E-03 |
| Normal-vs-Age(61-80Yrs) |
5.969000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.253000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.758600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.283800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.252800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.174200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.209400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.708800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.975000E-03 |
| Normal-VS-Type2 PRCC |
1.297630E-01 |
| Normal-VS-KIRP CIMP |
1.945530E-02 |
| Normal-VS-Unclassified PRCC |
3.828200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.019500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.278300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.541800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.227200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.903100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.665000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.090000E-01 |
| Normal-vs-N1 |
2.948400E-01 |
| Normal-vs-N2 |
3.345800E-01 |
| N0-vs-N1 |
9.403000E-01 |
| N0-vs-N2 |
8.870400E-01 |
| N1-vs-N2 |
9.156800E-01 |
|
|
